Our antibodies are used worldwide
We are the original manufacturer and provider of over 21,000 validated primary antibodies extensively covering the human proteome
May 2022 (Department of General Surgery, Fuyang Hospital Affiliated to Anhui Medical University, Fuyang, Anhui, China)
May 2022 (Technology Innovation Lab, New York Genome Center, USA)
"An open source toolkit for repurposing Illumina sequencing systems as versatile fluidics and imaging platforms".
Fluorescence microscopy is a crucial method in the life sciences. It requires automated execution to generate robust and reproducible data.
Accessibility to software, hardware, and protocol open platforms is therefore necessary to facilitate analysis and programmable applications without specialized engineering or software development expertise.
May 2022 (Department of Thyroid and Breast Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China)
April 2022 (German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany)
Mitochondrial energy production is finely tuned to interpret cellular needs accurately.
April 2022 (Center for Basic Research, Biomedical Research Foundation of the Academy of Athens, Greece)
RNF113A (Ring Finger Protein 113A) regulates survival and differentiation properties of neural stem cells.
April 2022 (Institute of Technology, University of Tartu, Nooruse 1, 50411 Tartu, Estonia)
Malignant melanoma is the most severe type of skin cancer with the highest mortality rate.
April 2022 (Institute of Pharmaceutical Sciences, Zurich, Switzerland)
March 2022 (Department of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, USA)
Lung cancer: deregulation of the ubiquitin-proteasome system promotes suppression of innate immunity, which fosters lung cancer immune evasion.
March, 2022 (Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Austria)
Muscle degeneration (or muscle atrophy) is the wasting or thinning of muscle mass that leads to frailty and dependency in inherited diseases and aging, affecting hundreds of millions of people.
March, 2022 (Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Italy)
February, 2022 (Laboratory of Biochemistry and Immunology, Osaka University, Japan)
February, 2022 (Department of Pathology and Medical Biology, University Medical Center Groningen, Netherlands)
January, 2022 (State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, China)
November, 2021 (Department of Clinical Medicine, College of Medicine, Hunan University of Chinese Medicine, China)
November, 2021 (Key Laboratory of Ministry of Education for Medicinal Plant Resource and Natural Pharmaceutical Chemistry, China)
September, 2021 (Department of Clinical Medicine - Department of Haematology, Aarhus, Denmark)
Novel putative protein biomarkers for colorectal cancer (CRC) identified by liquid chromatography-tandem mass spectrometry (LC-MS/MS) with future diagnostic potential.
September, 2021 (University of Copenhagen, Denmark)
ADP-ribosylation is a reversible post-translational protein modification that regulates numerous processes, including DNA damage repair and chromatin remodeling.
August, 2021 (Division of Oncology and Therapeutic Pathology, Department of Clinical Sciences, Lund University, Sweden)
Treatment options for patients with pancreatic cancer are limited, and chemotherapy remains the standard of care, leading to only modest survival benefits.
August, 2021 (Department of Gastroenterology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China)
July, 2021 (Molecular and Cellular Pharmacology Graduate Training Program, University of Wisconsin-Madison, USA)
June, 2021 (Department of Pediatric Immunology, Hacettepe University Medical School, Ankara, Turkey)
June, 2021 (Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea)
May, 2021 (Division of Oncology, Department of Clinical Sciences Lund, Lund University and Skåne University Hospital, Sweden)
May, 2021 (Institute of Immunity and Transplantation, University College London, United Kingdom)
Cytotoxic T-lymphocyte-associated protein 4, also known as CTLA-4 or CD152 (cluster of differentiation 152), is a protein receptor that functions as an immune checkpoint and downregulates immune responses.
April, 2021 (Department of Breast Surgery, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan)
April, 2021 (Institute for Research in Biomedicine, Barcelona, Spain)
The capacity to repair damaged DNA may modulate individual susceptibility to develop lung cancer.
April, 2021 (Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences, University Medical Center Utrecht, Netherlands)
Treatment options for patients with lacrimal gland disorders are limited partly due to a lack of biological understanding.
April, 2021 (Department of Biology, University of Waterloo, Ontario, Canada)
March, 2021 (Institute of Biomedicine and MediCity Research Laboratories, University of Turku, Finland)
March, 2021 (Hopp Children’s Cancer Center Heidelberg, Germany)
March, 2021 (Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan)
February, 2021 (Division of Cardiology, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, USA)